Libra et al. [23] also claimed that the GG genotype of IL-6 C-174G polymorphism might promote peripheral arterial disease development among individuals with T2DM by inducing increased release of IL-6 but without normal controls. The gene discussed is IL6; the disease is peripheral arterial disease.